218 related articles for article (PubMed ID: 31842924)
21. Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.
Chapy H; Saubaméa B; Tournier N; Bourasset F; Behar-Cohen F; Declèves X; Scherrmann JM; Cisternino S
Br J Pharmacol; 2016 Feb; 173(3):497-510. PubMed ID: 26507673
[TBL] [Abstract][Full Text] [Related]
22. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
23. Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells.
Goldeman C; Ozgür B; Brodin B
Fluids Barriers CNS; 2020 Apr; 17(1):32. PubMed ID: 32321539
[TBL] [Abstract][Full Text] [Related]
24. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.
Arduino I; Iacobazzi RM; Riganti C; Lopedota AA; Perrone MG; Lopalco A; Cutrignelli A; Cantore M; Laquintana V; Franco M; Colabufo NA; Luurtsema G; Contino M; Denora N
Int J Pharm; 2020 Dec; 591():120011. PubMed ID: 33115695
[TBL] [Abstract][Full Text] [Related]
25. Pioglitazone Increases Blood-Brain Barrier Expression of Fatty Acid-Binding Protein 5 and Docosahexaenoic Acid Trafficking into the Brain.
Low YL; Jin L; Morris ER; Pan Y; Nicolazzo JA
Mol Pharm; 2020 Mar; 17(3):873-884. PubMed ID: 31944767
[TBL] [Abstract][Full Text] [Related]
26. Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease model.
Puris E; Auriola S; Petralla S; Hartman R; Gynther M; de Lange ECM; Fricker G
Neurobiol Dis; 2022 Jul; 169():105741. PubMed ID: 35472634
[TBL] [Abstract][Full Text] [Related]
27. Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium.
Deutsch B; Neumeister C; Schwantes U; Fromm MF; König J
Mol Pharm; 2019 Feb; 16(2):510-517. PubMed ID: 30656943
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound.
Chaves JCS; Wasielewska JM; Cuní-López C; Rantanen LM; Lee S; Koistinaho J; White AR; Oikari LE
Neurotherapeutics; 2024 Jan; 21(1):e00299. PubMed ID: 38241156
[TBL] [Abstract][Full Text] [Related]
29. Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins.
Wu KC; Lu YH; Peng YH; Hsu LC; Lin CJ
J Neurochem; 2015 Dec; 135(6):1178-88. PubMed ID: 26376205
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening.
Kadoguchi M; Arakawa H; Honda R; Hotta K; Shirasaka Y; Deguchi Y; Tamai I
Pharm Res; 2022 Jul; 39(7):1549-1559. PubMed ID: 35314999
[TBL] [Abstract][Full Text] [Related]
31. Distinct roles of ezrin, radixin and moesin in maintaining the plasma membrane localizations and functions of human blood-brain barrier transporters.
Hoshi Y; Uchida Y; Kuroda T; Tachikawa M; Couraud PO; Suzuki T; Terasaki T
J Cereb Blood Flow Metab; 2020 Jul; 40(7):1533-1545. PubMed ID: 31409174
[TBL] [Abstract][Full Text] [Related]
32. Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients.
Al-Majdoub ZM; Al Feteisi H; Achour B; Warwood S; Neuhoff S; Rostami-Hodjegan A; Barber J
Mol Pharm; 2019 Mar; 16(3):1220-1233. PubMed ID: 30735053
[TBL] [Abstract][Full Text] [Related]
33. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
Müller F; König J; Hoier E; Mandery K; Fromm MF
Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
[TBL] [Abstract][Full Text] [Related]
34. Functional Investigation of Solute Carrier Family 35, Member F2, in Three Cellular Models of the Primate Blood-Brain Barrier.
Mochizuki T; Mizuno T; Kurosawa T; Yamaguchi T; Higuchi K; Tega Y; Nozaki Y; Kawabata K; Deguchi Y; Kusuhara H
Drug Metab Dispos; 2021 Jan; 49(1):3-11. PubMed ID: 33144341
[TBL] [Abstract][Full Text] [Related]
35. Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment.
Chaves JCS; Dando SJ; White AR; Oikari LE
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166967. PubMed ID: 38008230
[TBL] [Abstract][Full Text] [Related]
36. Increased Expression of Renal Drug Transporters in a Mouse Model of Familial Alzheimer's Disease.
Pan Y; Omori K; Ali I; Tachikawa M; Terasaki T; Brouwer KLR; Nicolazzo JA
J Pharm Sci; 2019 Jul; 108(7):2484-2489. PubMed ID: 30825461
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
38. Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model.
Ding Y; Zhong Y; Baldeshwiler A; Abner EL; Bauer B; Hartz AMS
Fluids Barriers CNS; 2021 Mar; 18(1):10. PubMed ID: 33676539
[TBL] [Abstract][Full Text] [Related]
39. Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced
Koepsell H
Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):635-653. PubMed ID: 33896325
[No Abstract] [Full Text] [Related]
40. Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.
Emmert D; Campos CR; Ward D; Lu P; Namanja HA; Bohn K; Miller DS; Sharom FJ; Chmielewski J; Hrycyna CA
ACS Chem Neurosci; 2014 Apr; 5(4):305-17. PubMed ID: 24483607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
